WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Jane Pritchett Henderson has joined the Company as Chief Financial and Business Officer. In this role, she will be responsible for Panacos’ financial operations, compliance and reporting, and corporate financing activities as well as contributing to corporate strategy.
